Ahmad Z Al Meslamani
Overview
Explore the profile of Ahmad Z Al Meslamani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramadan A, Jarab A, Al Meslamani A, Ahmed Mohamed Moustafa H, Kassem A, Abuelnor M, et al.
Curr Med Res Opin
. 2025 Feb;
:1-10.
PMID: 39996477
Purpose: Contraceptive use and associated adverse effects are underreported in the Middle East. This study aimed to investigate contraceptive use and reported side effects in five Middle Eastern countries. Methods:...
2.
Jarab A, Abu Heshmeh S, Al Meslamani A
Expert Opin Drug Saf
. 2025 Feb;
:1-9.
PMID: 39955621
Introduction: Biosimilars have transformed treatment modalities across various medical fields such as oncology, rheumatology, and immunology. Despite their potential for reducing healthcare costs, concerns persist regarding their ability to induce...
3.
H Abdel-Qader D, Abdel-Qader H, Silverthorne J, Kongkaew C, Al Nimrawi M, Al Meslamani A, et al.
PLoS One
. 2025 Jan;
20(1):e0312050.
PMID: 39752371
Background: There is a paucity of research regarding COVID-19 vaccines administration errors (VAEs) during the COVID-19 pandemic. This study aimed to investigate the prevalence, types, severity, causes and predictors of...
4.
Kassem A, Al Meslamani A, Elmaghraby D, Magdy Y, Abdelrahman M, Hamdan A, et al.
J Pharm Policy Pract
. 2024 Jul;
17(1):2372040.
PMID: 39011356
Introduction: Healthcare systems in developing countries faced significant challenges during COVID-19, grappling with limited resources and staffing shortages. Assessment of the impact of pharmaceutical care expertise, particularly in critical care...
5.
Jarab A, Abu Heshmeh S, Al Meslamani A
Hum Vaccin Immunother
. 2024 Jun;
20(1):2362450.
PMID: 38887055
Biosimilar vaccines and immunotherapeutic are innovative approaches in medical research. This commentary addresses the current disparities in regulations of biosimilar vaccines and immunotherapeutic products across different nations. It also navigates...
6.
Al Meslamani A, Sobrino I, de la Fuente J
Ann Med
. 2024 Jun;
56(1):2362869.
PMID: 38853633
Infectious diseases are a major threat for human and animal health worldwide. Artificial Intelligence (AI) combined algorithms including Machine Learning and Big Data analytics have emerged as a potential solution...
7.
Al Meslamani A
Expert Opin Biol Ther
. 2024 May;
24(5):317-319.
PMID: 38785080
No abstract available.
8.
Al Meslamani A, Merghani Ali E
Expert Rev Clin Immunol
. 2024 May;
20(9):1023-1025.
PMID: 38716705
No abstract available.
9.
Al Meslamani A
Expert Rev Anti Infect Ther
. 2024 May;
22(7):497-499.
PMID: 38697811
No abstract available.
10.
Jarab A, Abu Heshmeh S, Al Meslamani A
Int J Pharm Pract
. 2024 Apr;
32(3):256-258.
PMID: 38558133
No abstract available.